Published in Nucleic Acids Res on December 01, 2002
CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature (2011) 3.72
Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet (2006) 2.02
A comprehensive literature review of haplotyping software and methods for use with unrelated individuals. Hum Genomics (2005) 1.84
Reconstructing patterns of reticulate evolution in plants. Am J Bot (2004) 1.79
PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res (2004) 1.74
Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations. Am J Hum Genet (2003) 1.66
Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB). Genome Res (2007) 1.22
SNP-VISTA: an interactive SNP visualization tool. BMC Bioinformatics (2005) 1.21
GEVALT: an integrated software tool for genotype analysis. BMC Bioinformatics (2007) 0.98
Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res (2009) 0.94
A survey of current software for haplotype phase inference. Hum Genomics (2004) 0.94
A double classification tree search algorithm for index SNP selection. BMC Bioinformatics (2004) 0.93
Haploscope: a tool for the graphical display of haplotype structure in populations. Genet Epidemiol (2011) 0.79
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The human genome browser at UCSC. Genome Res (2002) 168.23
The sequence of the human genome. Science (2001) 101.55
A new statistical method for haplotype reconstruction from population data. Am J Hum Genet (2001) 59.30
Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet (2001) 53.16
The structure of haplotype blocks in the human genome. Science (2002) 50.88
Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Prediction of deleterious human alleles. Hum Mol Genet (2001) 21.00
High-resolution haplotype structure in the human genome. Nat Genet (2001) 20.51
Inference of haplotypes from PCR-amplified samples of diploid populations. Mol Biol Evol (1990) 16.18
Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science (2001) 15.54
DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet (1998) 11.70
Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Sequence variation in the human angiotensin converting enzyme. Nat Genet (1999) 10.12
Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56
BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. Cell (2001) 5.05
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
PowerBLAST: a new network BLAST application for interactive or automated sequence analysis and annotation. Genome Res (1997) 4.10
Bayesian analysis of haplotypes for linkage disequilibrium mapping. Genome Res (2001) 3.49
A space-efficient algorithm for local similarities. Comput Appl Biosci (1990) 2.98
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet (2000) 2.62
Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. Mol Cell (2000) 1.91
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.20
ViewGene: a graphical tool for polymorphism visualization and characterization. Genome Res (2002) 1.11
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48
PID: the Pathway Interaction Database. Nucleic Acids Res (2008) 12.92
SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput Biol (2005) 10.04
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
The BioPAX community standard for pathway data sharing. Nat Biotechnol (2010) 9.19
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
caCORE: a common infrastructure for cancer informatics. Bioinformatics (2003) 7.07
Global transcription in pluripotent embryonic stem cells. Cell Stem Cell (2008) 5.81
Allelic variation in gene expression is common in the human genome. Genome Res (2003) 5.50
An anatomy of normal and malignant gene expression. Proc Natl Acad Sci U S A (2002) 4.45
Long-range heterogeneity at the 3' ends of human mRNAs. Genome Res (2002) 3.91
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. Clin Cancer Res (2005) 3.79
CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature (2011) 3.72
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet (2007) 3.63
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2011) 3.40
Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res (2003) 2.84
FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet (2009) 2.62
Detecting false expression signals in high-density oligonucleotide arrays by an in silico approach. Genomics (2005) 2.61
Genome-wide association study in esophageal cancer using GeneChip mapping 10K array. Cancer Res (2005) 2.22
The completion of the Mammalian Gene Collection (MGC). Genome Res (2009) 2.21
Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS One (2007) 2.18
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol (2005) 2.11
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study. J Natl Cancer Inst (2003) 2.04
Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet (2006) 2.02
Large-scale analysis of non-synonymous coding region single nucleotide polymorphisms. Bioinformatics (2004) 1.99
Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology (2010) 1.97
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiol Biomarkers Prev (2007) 1.75
Allele-specific chromatin immunoprecipitation studies show genetic influence on chromatin state in human genome. PLoS Genet (2007) 1.71
Genomewide distribution of high-frequency, completely mismatching SNP haplotype pairs observed to be common across human populations. Am J Hum Genet (2003) 1.66
Bambino: a variant detector and alignment viewer for next-generation sequencing data in the SAM/BAM format. Bioinformatics (2011) 1.61
Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet (2007) 1.55
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. BMC Genet (2008) 1.53
Meeting research needs with postmortem biospecimen donation: summary of recommendations for postmortem recovery of normal human biospecimens for research. Biopreserv Biobank (2013) 1.51
A high-resolution multistrain haplotype analysis of laboratory mouse genome reveals three distinctive genetic variation patterns. Genome Res (2005) 1.50
Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. Blood (2012) 1.47
The cancer genome anatomy project: online resources to reveal the molecular signatures of cancer. Cancer Invest (2002) 1.46
Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. Genome Res (2003) 1.41
Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists. Am J Epidemiol (2006) 1.37
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer (2004) 1.36
e-Science, caGrid, and Translational Biomedical Research. Computer (Long Beach Calif) (2008) 1.32
Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists. Int J Cancer (2008) 1.26
Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB). Genome Res (2007) 1.22
A genome scan of 18 families with chronic lymphocytic leukaemia. Br J Haematol (2003) 1.18
Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res (2003) 1.13
Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer. Cancer Res (2003) 1.12
Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array. BMC Genomics (2006) 1.09
The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat (2006) 1.09
Infrastructure for a learning health care system: CaBIG. Health Aff (Millwood) (2009) 1.07
A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer (2002) 1.05
Bioinformatics tools for single nucleotide polymorphism discovery and analysis. Ann N Y Acad Sci (2004) 1.04
Integrated cross-species transcriptional network analysis of metastatic susceptibility. Proc Natl Acad Sci U S A (2012) 1.03
Comparative sequence analysis of imprinted genes between human and mouse to reveal imprinting signatures. Genomics (2004) 1.02
Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. Genet Epidemiol (2006) 1.02
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history. Epidemiology (2002) 1.02
A computational approach to measuring coherence of gene expression in pathways. Genomics (2004) 1.01
Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS One (2009) 1.01
Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev (2007) 0.98
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families. Breast Cancer Res Treat (2010) 0.97
Direct ampholyte-free liquid-phase isoelectric peptide focusing: application to the human serum proteome. Electrophoresis (2004) 0.96
The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2006) 0.96
Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res (2009) 0.94
Detecting cancer gene networks characterized by recurrent genomic alterations in a population. PLoS One (2011) 0.94
Genetic susceptibility and dietary patterns in lung cancer. Lung Cancer (2003) 0.93
DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. Mutat Res (2005) 0.92
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer (2004) 0.92
BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. Am J Med Genet A (2004) 0.92
ATG deserts define a novel core promoter subclass. Genome Res (2005) 0.92
Superposition of transcriptional behaviors determines gene state. PLoS One (2008) 0.91
Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer development. Oncology (2002) 0.91
CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF. Oncogene (2003) 0.90
Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev (2008) 0.90
Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial. Int J Mol Epidemiol Genet (2010) 0.88
Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists. Breast Cancer Res Treat (2009) 0.86
Life sciences domain analysis model. J Am Med Inform Assoc (2012) 0.85
CHEK2:1100delC and female breast cancer in the United States. Int J Cancer (2004) 0.85
BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. Am J Med Genet A (2005) 0.84
Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst (2003) 0.84
Cyberinfrastructure and the biomedical sciences. Am J Prev Med (2011) 0.83
Hemochromatosis gene mutations and distal adenomatous colorectal polyps. Cancer Epidemiol Biomarkers Prev (2005) 0.82
A phylogenetic analysis identifies heterogeneity among hepatocellular carcinomas. Hepatology (2002) 0.81
Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes. Cancer Epidemiol Biomarkers Prev (2003) 0.81
Breast cancer risks for BRCA1/2 carriers. Science (2004) 0.80
BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening. Am J Med Genet A (2006) 0.80
Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999. Eur J Med Genet (2007) 0.79
Genome-wide transcriptional sequencing identifies novel mutations in metabolic genes in human hepatocellular carcinoma. Cancer Genomics Proteomics (2014) 0.78
Systems analysis utilising pathway interactions identifies sonic hedgehog pathway as a primary biomarker and oncogenic target in hepatocellular carcinoma. IET Syst Biol (2013) 0.77